R&D Spotlight:
Proteomic Biomarkers Insights

19 November 2026 | Online, GMT (UTC+0)

SPONSORED BY

Oxford Global Logo Standard

SPONSORED BY

215b0b1a-7102-4393-9681-94c302209322-2-5668375logo-illumina-full_logo-CMYK-pumpkin

This showcase spotlights the evolving landscape of proteomics in biomarker discovery and clinical development

Featuring success stories from leading organisations, the session will explore how advances in mass spectrometry, translational tools, and clinical assay development are driving more precise and actionable insights across therapeutic areas.

  • Showcase Your Technology to a Targeted Audience - Position your platform directly in front of decision-makers from pharma, biotech, and academia actively working in proteomics, biomarker discovery, and clinical development
  • Demonstrate Real-World Impact Through a Featured Talk - Present alongside a leading industry speakers to highlight how your solutions are being applied.
  • Align Your Brand with Innovation in Proteomics - Gain visibility as a thought leader by contributing to discussions on emerging proteomic tools, mass spectrometry workflows, and biomarker validation techniques
  • Engage Directly with Senior Stakeholders - Take part in live Q&A and interactive segments designed to foster meaningful connections with your ideal customers and collaborators.

This is your chance to see the latest tools in action, understand their real-world impact, and leave with practical takeaways to apply in your own research.

VPs, Directors & Senior Managers from leading pharma & biotech companies and research institutions in the following fields and more:

 

  • Proteomics
  • Biomarker Development 
  • Translational Research
  • Mass Spectrometry

60-Minute Agenda

14:00 - 14:15

LC-MS Proteomics - Weighing Thousands Of Proteins At Once To Understand Biology

Jan Schejbal
Senior Scientist II, QTAS Translational Protein Analytics, AbbVie
14:15 – 14:30

Leveling Up: Spatial Proteomics to Spatial Omics

Kimberly Smythe
Laboratory Head & Staff Scientist, Fred Hutch Cancer Centre
14:30 – 14:45

Illumina Presentation

14:45 – 15:00

Panel Discussion: Application and Integration Of Proteomic Biomarkers In Precision Medicine

  • How will proteomics power the future of precision medicine?
  • Clinical proteomics to transform diagnostic and therapeutic approaches
  • Where are developments imminent? Projections for the next year
All Spotlight speakers will join the panel.
15:00

End of Technology Showcase

Agenda

13:40 – 14:00

Industry Presentation: TACAs: Opening up the Target Space to a New Frontier

PETER SONDERMANN
Chief Executive Officer, Tacalyx
14:00 – 14:20

Industry Presentation: Innovative Strategies For Efficient NK Cell Redirection

LUKAS PEKAR
Lab Head, Merck KGaA
14:20 – 14:40

Solution Provider Presentation

For sponsorship opportunities please contact: sponsorship@oxfordglobal.com
14:40 – 15:00

See The Technology In Action + Live Q&A

15:00

End of Technology Showcase

About Technology Showcases

Our Technology Showcases are interactive, online events that bring together leading experts and innovators to share insights on the latest technology in a specific field.

This series is designed for industry professionals, scientists and researchers to stay ahead of the latest innovations. Each showcase spotlights a critical real-world success story, where leading experts share how cutting-edge technologies are transforming research and overcoming key challenges.

Each showcase features two expert talks from leaders in the field, followed by an in-depth exploration and demonstration of new technologies from our Solution Providers and a live Q&A. Gain practical insights and witness technologies in action.